2’-O-(2-Methoxyethyl) inosine

Cat. No.: HY-152516 Pureza: 97.0%: Ficha de datos
COA

SDS
Instrucciones de manejo
FAQs
Technical Support

2’-O-(2-Methoxyethyl) inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.

Para uso exclusivo en investigación. No vendemos a pacientes.

2’-O-(2-Methoxyethyl) inosine Estructura química

No. CAS : 545374-76-3

Tamaño	Stock	Cantidad
5 mg	En stock	Estimated Time of Arrival: December 31
10 mg	En stock	Estimated Time of Arrival: December 31
25 mg	En stock	Estimated Time of Arrival: December 31
50 mg	En stock	Estimated Time of Arrival: December 31
100 mg	En stock	Estimated Time of Arrival: December 31
200 mg	Obtener un presupuesto
500 mg	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Revisión del cliente

Based on 1 Customer Validation

Recomendaciones destacadas

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn	2’-O-(2-Methoxyethyl) inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc^[1].
Peso molecular	326.31
Fòrmula	C₁₃H₁₈N₄O₆
No. CAS	545374-76-3
Appearance	Solid
Color	White to off-white
SMILES	O[C@H]1[C@@H](OCCOC)[C@H](N(C=N2)C3=C2C(NC=N3)=O)O[C@@H]1CO
Envío	Room temperature in continental US; may vary elsewhere.
Almacenamiento	4°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Pureza y Documentación	Purity: 97.0% Select Batch: Ficha de datos (270 KB) SDS (252 KB) COA (253 KB) HNMR (105 KB) Instrucciones de manejo (2659 KB)
Referencias	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [Content Brief]